In a report issued on November 30, Whit Mayo from Leerink Partners reiterated a Buy rating on UnitedHealth (UNH – Research Report), with a price target of $480.00. The company's shares closed last Wednesday at $444.34, close to its 52-week high of $466.00. According to TipRanks.com, Mayo is a 4-star analyst with an average return of 7.0% and a 52.0% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Oak Street Health, and Surgery Partners. The word on The Street in general, suggests a Strong Buy analyst consensus rating for UnitedHealth with a $488.17 average price target, implying a 7.8% upside from current levels.
https://www.tipranks.com/news/blurbs/leerink-partners-believes-unitedhealth-unh-wont-stop-here?utm_source=advfn.com&utm_medium=referral
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De Dic 2021 a Ene 2022 Haga Click aquí para más Gráficas UnitedHealth.
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De Ene 2021 a Ene 2022 Haga Click aquí para más Gráficas UnitedHealth.